KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Short term Debt (2020 - 2023)

Clover Health Investments' Short term Debt history spans 4 years, with the latest figure at $1.3 million for Q1 2023.

  • For Q1 2023, Short term Debt fell 31.74% year-over-year to $1.3 million; the TTM value through Mar 2023 reached $1.3 million, down 31.74%, while the annual FY2022 figure was $1.6 million, 32.5% down from the prior year.
  • Short term Debt reached $1.3 million in Q1 2023 per CLOV's latest filing, down from $1.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.3 million in Q4 2021 to a low of $1.3 million in Q1 2023.
  • Average Short term Debt over 4 years is $1.7 million, with a median of $1.6 million recorded in 2022.
  • Peak YoY movement for Short term Debt: surged 49.97% in 2021, then crashed 32.5% in 2022.
  • A 4-year view of Short term Debt shows it stood at $1.5 million in 2020, then soared by 49.97% to $2.3 million in 2021, then tumbled by 32.5% to $1.6 million in 2022, then decreased by 15.01% to $1.3 million in 2023.
  • Per Business Quant, the three most recent readings for CLOV's Short term Debt are $1.3 million (Q1 2023), $1.6 million (Q4 2022), and $1.7 million (Q3 2022).